Detalhe da pesquisa
1.
Concise Review: Heart-Derived Cell Therapy 2.0: Paracrine Strategies to Increase Therapeutic Repair of Injured Myocardium.
Stem Cells
; 36(12): 1794-1803, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171743
2.
Hyperglycemia inhibits cardiac stem cell-mediated cardiac repair and angiogenic capacity.
Circulation
; 130(11 Suppl 1): S70-6, 2014 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25200058
3.
Increase of autophagy and attenuation of apoptosis by Salvigenin promote survival of SH-SY5Y cells following treatment with H2O2.
Mol Cell Biochem
; 371(1-2): 9-22, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22899171
4.
Mybl2 rejuvenates heart explant-derived cells from aged donors after myocardial infarction.
Aging Cell
; 19(7): e13174, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558221
5.
Glyoxalase 1 Prevents Chronic Hyperglycemia Induced Heart-Explant Derived Cell Dysfunction.
Theranostics
; 9(19): 5720-5730, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31534514
6.
Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.
J Am Heart Assoc
; 4(9): e002104, 2015 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26363004
7.
The Frustration and Futility of Intracoronary Stem Cell Therapy.
Can J Cardiol
; 33(12): 1510-1512, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29092749